Heptares Therapeutics Limited
Patents = 85
Trademarks = 3
Forward Citations = 745
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
74 inventors (with patents filed for the assignee):
Heptares Therapeutics Limited is a clinical-stage biotechnology company that specializes in the discovery and development of small-molecule drugs that target G protein-coupled receptors (GPCRs). With a focus on GPCRs in the areas of neuroscience, oncology, and rare diseases, Heptares utilizes its proprietary structure-based drug design platform, StaR technology, to create novel therapeutics. The company has a strong pipeline of potential drug candidates and collaborations with pharmaceutical partners to advance the development and commercialization of innovative medicine.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com